Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Obesity (Silver Spring) ; 18(3): 441-8, 2010 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-19696763

RESUMEN

Hyperandrogenemia predisposes an organism toward developing impaired insulin sensitivity. The aim of our study was to evaluate endocrine and metabolic effects during early allostasis induced by a fructose-rich diet (FRD) in normal (control; CT) and neonatal-androgenized (testosterone propionate; TP) female adult rats. CT and TP rats were fed either a normal diet (ND) or an FRD for 3 weeks immediately before the day of study, which was at age 100 days. Energy intake, body weight (BW), parametrial (PM) fat characteristics, and endocrine/metabolic biomarkers were then evaluated. Daily energy intake was similar in CT and TP rats regardless of the differences in diet. When compared with CT-ND rats, the TP-ND rats were heavier, had larger PM fat, and were characterized by basal hypoadiponectinemia and enhanced plasma levels of non-esterified fatty acid (NEFA), plasminogen activator inhibitor-1 (PAI-1), and leptin. FRD-fed CT rats, when compared with CT-ND rats, had high plasma levels of NEFA, triglyceride (TG), PAI-1, leptin, and adiponectin. The TP-FRD rats, when compared with TP-ND rats, displayed enhanced leptinemia and triglyceridemia, and were hyperinsulinemic, with glucose intolerance. The PM fat taken from TP rats displayed increase in the size of adipocytes, decrease in adiponectin (protein/gene), and a greater abundance of the leptin gene. PM adipocyte response to insulin was impaired in CT-FRD, TP-ND, and TP-FRD rats. A very short duration of isocaloric FRD intake in TP rats induced severe metabolic dysfunction at the reproductive age. Our study supports the hypothesis that the early-androgenized female rat phenotype is highly susceptible to developing endocrine/metabolic dysfunction. In turn, these abnormalities enhance the risk of metabolic syndrome, obesity, type 2 diabetes, and cardiovascular disease.


Asunto(s)
Tejido Adiposo/metabolismo , Andrógenos/metabolismo , Fructosa/farmacología , Trastornos del Metabolismo de la Glucosa/etiología , Hiperandrogenismo/complicaciones , Obesidad/etiología , Adipocitos/patología , Adipoquinas/metabolismo , Adiponectina/metabolismo , Adiposidad , Animales , Peso Corporal , Sacarosa en la Dieta/administración & dosificación , Sacarosa en la Dieta/farmacología , Modelos Animales de Enfermedad , Ingestión de Energía , Ácidos Grasos no Esterificados/sangre , Femenino , Genitales Femeninos , Trastornos del Metabolismo de la Glucosa/sangre , Trastornos del Metabolismo de la Glucosa/metabolismo , Hiperandrogenismo/sangre , Insulina/metabolismo , Leptina/sangre , Leptina/genética , Obesidad/sangre , Inhibidor 1 de Activador Plasminogénico/sangre , Ratas , Ratas Sprague-Dawley , Factores de Riesgo , Propionato de Testosterona/metabolismo , Triglicéridos/sangre
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA